<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="30/10/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8562886" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8562886</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The effect of <term sem="Organic_compound_other" id="T1" lex="Toremifene">Toremifene</term> on the expression of some <term sem="DNA_domain_or_region" id="A1">genes</term> in <term sem="Cell_natural" id="T2" lex="human_mononuclear_cell">human mononuclear cells</term>.</sentence>
<event id="E1">
<type class="Gene_expression" />
<theme idref="A1" />
<clue>The effect of Toremifene on the <clueType>expression</clueType> <linkTheme>of</linkTheme> some genes in human mononuclear cells.</clue>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref="E1" />
<cause idref="T1" />
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> Toremifene <linkTheme>on</linkTheme> the expression of some genes <clueLoc>in human mononuclear cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Organic_compound_other" id="T3" lex="Toremifene">Toremifene</term> exerts multiple and varied effects on the <term sem="Other" id="T4" lex="gene_expression">gene expression</term> of <term sem="Cell_natural" id="T5" lex="human_peripheral_mononuclear_cell">human peripheral mononuclear cells</term>.</sentence>
<event id="E3">
<type class="Regulation" />
<theme idref="T4" />
<cause idref="T3" />
<clue>Toremifene exerts multiple and varied <clueType>effects</clueType> <linkTheme>on</linkTheme> the gene expression <clueLoc>of human peripheral mononuclear cells.</clueLoc></clue>
</event>
<sentence id="S3">After short-term, <term sem="Other" id="T6" lex="in_vitro_exposure">in vitro exposure</term> to <term sem="Other" id="T7" lex="therapeutical_level">therapeutical levels</term>, distinct changes in <cons sem="(AND Other Other Other Other)" id="T8" lex="(AND P-glycoprotein_expression steroid_receptors_expression p53_expression Bcl-2_expression)"><frag id="F1"><term sem="Protein_molecule" id="A2">P-glycoprotein</term></frag>, <frag id="F2"><term sem="Protein_molecule" id="A3">steroid receptors</term></frag>, <frag id="F3"><term sem="Protein_molecule" id="A4">p53</term></frag> and <frag id="F4"><term sem="Protein_molecule" id="A5">Bcl-2</term></frag> <frag id="F5">expression</frag></cons> take place.</sentence>
<event id="E4">
<type class="Gene_expression" />
<theme idref="A2" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E5">
<type class="Gene_expression" />
<theme idref="A3" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E6">
<type class="Gene_expression" />
<theme idref="A4" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E7">
<type class="Gene_expression" />
<theme idref="A5" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E8">
<type class="Artificial_process" />
<theme idref="T3" />
<clue>After short-term, in vitro <clueType>exposure</clueType> to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E9">
<type class="Regulation" />
<theme idref="E4" />
<cause idref="E8" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<event id="E10">
<type class="Regulation" />
<theme idref="E5" />
<cause idref="E8" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<event id="E11">
<type class="Regulation" />
<theme idref="E6" />
<cause idref="E8" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<event id="E12">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="E8" />
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<sentence id="S4">In view of the increasing use of <term sem="Lipid" id="T9" lex="antiestrogen">antiestrogens</term> in <term sem="Other" id="T10" lex="cancer_therapy">cancer therapy</term> and <term sem="Other" id="T11" lex="cancer_prevention">prevention</term>, there is obvious merit in <term sem="Other" id="T12" lex="long-term_in_vivo_study">long-term in vivo studies</term> to be conducted.</sentence>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
